PathoLecoDeco2 Flashcards
(1217 cards)
Histopathology - Neuro-oncology
Usually 1st and 2nd decade - 20% of CNS tumours below 14 years
Common in NF1
MRI: well circumscribed, cystic, enhancing lesion
Often cerebellar, optic-hypothalamic, brainstem
Hallmark: piloid “hairy” cell
Very often Rosenthal fibres and granular bodies
Slowly growing: low mitotic activity
BRAF mutation (KIAA1549-BRAF fusion) in 70% of PA
PILOCYTIC ASTROCYTOMA (WHO GRADE I)
Histopathology - Neuro-oncology
Hallmark: piloid “hairy” cell
Very often Rosenthal fibres and granular bodies
Slowly growing: low mitotic activity
PILOCYTIC ASTROCYTOMA (WHO GRADE I)
Histopathology - Neuro-oncology
Patients usually 20-40 years
MRI: T1 hypointense, T2 hyperintense, non-enhancing lesion.
Low choline / creatinine ratio at MRSpec.
Low to moderate cellularity
Mitotic activity is negligible or absent
Vascular proliferation and necrosis are absent
Mutation of IDH1/2: in >80% of cases
DIFFUSE ASTROCYTOMA (GRADE II)
Histopathology - Neuro-oncology
Low to moderate cellularity
Mitotic activity is negligible or absent
Vascular proliferation and necrosis are absent
Mutation of IDH1/2: in >80% of cases
What tumour?
DIFFUSE ASTROCYTOMA (GRADE II)
Histopathology - Neuro-oncology
Where do most astrocytomas present?
Cerebral hemispheres most common site
Progression to higher grade is the rule:
astrocytomas become eventually glioblastoma (in 5-7 years)
Most aggressive and most frequent: de novo glioblastoma (grade IV), IDH wildtype
Histopathology - Neuro-oncology
Most patients >50 years
MRI: heterogeneous, enhancing post-contrast
High cellularity and high mitotic activity microvascular proliferation, necrosis
GLIOBLASTOMA MULTIFORME (GRADE IV)
Histopathology - Neuro-oncology
High cellularity and high mitotic activity microvascular proliferation, necrosis
GLIOBLASTOMA MULTIFORME (GRADE IV)
Histopathology - Neuro-oncology
5% of all primary brain tumours
Patients usually 20-40 years
Presents with long history of neurological signs – seizure
MRI: no or patchy contrast enhancement; MRI and MRSpec are not predictive of transformation
Round cells with clear cytoplasm (“fried eggs”)
Mutation of IDH1/2 + codeletion 1p/19q: almost 100%
OLIGODENDROGLIOMA (GRADE II – III)
Histopathology - Neuro-oncology
Presents with long history of neurological signs – seizure
MRI: no or patchy contrast enhancement; MRI and MRSpec are not predictive of transformation
Round cells with clear cytoplasm (“fried eggs”)
OLIGODENDROGLIOMA (GRADE II – III)
Histopathology - Neuro-oncology
25-30% primary intracranial tumours – second after gliomas
Rare in patients < 40
Any site of craniospinal axis, can be multiple (NF2)
Focal symptoms (seizures, compression)
MRI: extraxial, isodense, contrast-enhancing
80% Grade I: benign, recurrence <25%
20% Grade II: atypical, recurrence 25-50%
1% Grade III: malignant, recurrence 50-90%
MENINGIOMA (WHO GRADE I – III)
Histopathology - Neuro-oncology
MRI: extraxial, isodense, contrast-enhancing
MENINGIOMA (WHO GRADE I – III)
Histopathology - Neuro-oncology
Grading (I-III) currently based on histology only:
no radiological features
Complex assessment: proliferation, cell morphology, architecture,
brain invasion…
True or false?
T
Most meningiomas are
benign and slowly growing
Histology is crucial
Histopathology - Neuro-oncology
What mitoses indicates grades 1/2/3?
<4 = grade I
4-20 = grade II
> 20 = grade III
Crucial: determines grade
Time consuming: cases must be thoroughly examined (even 100 fields or more)
Histopathology - Neuro-oncology
EMBRYONAL TUMOUR: originates from neuroepithelial precursors of the cerebellum/dorsal brainstem
Rare (2 per 1,000,000 year), but second most common brain tumour in children
“Small blue round cell tumour” with expression of neuronal markers
Molecular classification: WNT-activated, SHH-activated,
non-WNT/non-SHH
Outcome considerably improved with radio-chemotherapy
MEDULLOBLASTOMA (WHO GRADE IV)
Medullo-blue
Histopathology - Neuro-oncology
second most common brain tumour in children
MEDULLOBLASTOMA (WHO GRADE IV)
Histopathology - Neuro-oncology
Most frequent CNS tumour in adults (10 x intrinsic tumours)
Increasing incidence due to longer survival
Often multiple
At gray– white junction
Very poor prognosis
CNS METASTASES
Histopathology - Neurodegeneration
What is a prion disease?
Prion (proteinaceous infectious only)
A series of diseases with common molecular pathology
Transmissible factor
No DNA or RNA involved
Histopathology - Neurodegeneration
Name 2 prion diseases?
Humans Creutzfeldt-Jakob disease Gerstmann-Straüssler-Sheinker syndrome Kuru Fatal familial insomnia
Histopathology - Neurodegeneration
When do patients present with vCJD?
Sporadic neuropsychiatric disorder Patients <45 yrs old Cerebellar ataxia Dementia Longer duration than CJD Linked to BSE Diagnosed at autopsy since 1990 up to 2 Jul 2018 178 deaths
Histopathology - Neurodegeneration
What are the Sx of vCJD
Sporadic neuropsychiatric disorder Patients <45 yrs old Cerebellar ataxia Dementia Longer duration than CJD Linked to BSE Diagnosed at autopsy since 1990 up to 2 Jul 2018 178 deaths
Histopathology - Neurodegeneration
Extracellular plaques
Neurofibrillary tangles
Cerebral amyloid angiopathy (CAA)
Neuronal loss (cerebral atrophy)
Alzheimer’s
Histopathology - Neurodegeneration
What is the Neuropathology of Alzheimers
Extracellular plaques
Neurofibrillary tangles
Cerebral amyloid angiopathy (CAA)
Neuronal loss (cerebral atrophy)
Histopathology - Neurodegeneration
Cortical atrophy
Senile Plaques
Cerebral amyloid angiopathy
Alzheimer’s
Histopathology - Neurodegeneration
APP
Alzheimer’s